Research Sample bioBank

Can’t find what you’re looking for? Contact us.

Or, need help ordering? 805.528.4341

Filter Samples By:

Get Weekly Research Sample Updates in your Inbox:

Stomach Cancer Clinical Research Samples

Discovery Life Sciences provides the highest quality Stomach Cancer Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank. 

  • All Stomach Cancer Sample Orders are Packaged for Delivery within 24 Hours. 
  • All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
  • Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
  • Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations. 
Showing 46 of 46 total samples
 (0)
Checkout
Advanced Data View:
Showing 46 of 46 total samples
Buy
Product IDSampleOriginMatrixVial (ml)QuantityPriceAgeGenderEthnicityStorage TempSample DateTest 1Test Data 1Detail 1Test 2Test Data 2Detail 2Test 3Test Data 3Detail 3Product
Details
Price
Buy
Blood TypeCo-morbiditiesConsent Status DateCurrent MedicationsHeightWeightMenopausal StatusSmoking NotesICD10 codesSite of Primary TumorHistory of Benign Disease Prior to Cancer DiagnosisSite of MetastasisAny Previous Form of CancerBiomarker Testing InformationEsophagogastroduodenoscopyX-RayBiopsyHIV-I/II | HBC | HCV ResultAlcohol ConsumptionSurgical ProcedureTumor InformationMicroscopic descriptionConclusion of the pathologist
BBS0000-CV900097980101416DDStomach CancerVietnamSerum1.001.00$150.0057 YFemaleNon-Hispanic<-70C14-Oct-16Clinical DiagnosisStomach CancerStagingTumor T0Additional InformationStomach cancer peritoneal metastasis was diagnosed 01/2016. Cell: ring cell carcinoma.$150.00UnknownMenopausalNon-smokerStomachNo
BBS0000-CV900398758030619D4Stomach CancerVietnamSerum0.353.00$150.0063 YMaleNon-Hispanic<-70C06-Mar-19Clinical DiagnosisStomach CancerStagingII; T2NXM0Date of Primary Tumor Diagnosis2019-03-04$150.00Unknown2019-03-06Nexium65.75117StomachNoneU/ANoCA 72-4: 1.56 U/mL | CEA: 6.18 U/mL | 27-Feb-2019 |
BBS0000-CV900398763030719DDStomach CancerVietnamSerum0.352.00$150.0069 YMaleNon-Hispanic<-70C07-Mar-19Clinical DiagnosisStomach CancerStagingIV; T3N3MXDate of Primary Tumor Diagnosis2019-02-25$150.00Unknown2019-03-07Omeprazole, Amlodipine62.60128StomachHypertensionLymph nodesNoCEA: 3.75 U/mL | 19-Feb-2019 |
BBS0000-G2900365161112919DDStomach CancerUkraineSerum0.5010.00Special Order.
Please Inquire
56 YFemaleNon-Hispanic<-70C29-Nov-19Clinical DiagnosisCancer of the stomach, T1-2NxM0, stage IIDisease StatusPrimaryMost Recent StagingT3N0M0; IIA, G3Special Order.
Please Inquire
UnknownEssential hypertension, grade II2019-11-2967.72243Never usedGastrointestinal tract | There is a neoplastic process of the stomach, an infiltrative form.
2019-11-14
Stomach | There is a defect in the lower third of the body of the stomach with a transition to the antrum.
2019-11-20
Stomach | There is a carcinoma, G3.
2019-11-19
Negative
2019-11-29
Never usedSubtotal gastrectomy | Stomach, NOS
2019-11-29
Body of stomach
3.0 x 1.4
Carcinoma of the stomach, G3. Tumor penetrates the subserosal connective tissue. There are signs of lymphovascular invasion. No perineural invasion. There are no metastases in the lymph nodes.Carcinoma
EDP0000-AA900022548080319DDStomach CancerRussiaK2 EDTA Plasma1.252.00$150.0059 YFemaleNon-Hispanic<-70C03-Aug-19Clinical DiagnosisAdenocarcinoma of StomachEndoscopy, Ultrasound and CTStagingIib, T3N1M0G212-Aug-19Date of Initial Primary Tumor Diagnosis19-Jul-19$150.00UnknownNoneNoneFormer 10-15 cigs/day for over 10 yearsC16.2StomachChronic gastritisN/ANo
EDP0000-AA900031115080419DDStomach CancerRussiaK2 EDTA Plasma1.002.00$150.0054 YFemaleNon-Hispanic<-70C04-Aug-19Clinical DiagnosisAdenocarcinoma of StomachEndoscopy, Ultrasound, CT and MRIStagingIib, T3NXM0G312-Aug-19Date of Initial Primary Tumor Diagnosis12-Jul-19$150.00UnknownNoneNoneNAC16.3StomachGastric ulcer, Chronic gastroduodenitisN/ANo
EDP0000-AA900037629062819DDStomach CancerRussiaK2 EDTA Plasma1.002.00$150.0072 YMaleNon-Hispanic<-70C28-Jun-19Clincal DiagnosisAdenocarcinoma of StomachMost Recent StagingIia; T3N0M0G27-Jul-19Date of Initial Primary Tumor Diagnosis16-Jun-19$150.00UnknownNoneUnknownFormer 15-20 cigs/day for over 25 yearsC16.2StomachGastric ulcerU/A
EDP0000-AA900037631060519DDStomach CancerRussiaK2 EDTA Plasma1.002.00$150.0051 YFemaleNon-Hispanic<-70C05-Jun-19Clinical DiagnosisAdenocarcinoma of StomachEndoscopy, Ultrasound, CT and MRIStagingIia, T2NXM0G316-Jun-19Date of Initial Primary Tumor Diagnosis20-May-19$150.00UnknownNoneNoneCurrent 10-15 cigs/day for over 20 yearsC16.1StomachNoN/ANo
EDP0000-AA900099086070219DDStomach CancerRussiaK2 EDTA Plasma1.002.00$150.0060 YFemaleHispanic<-70C02-Jul-19Clinical DiagnosisAdenocarcinoma of StomachEndoscopy, CT and MRIStagingIib, T1N2M0G311-Jul-19Date of Initial Primary Tumor Diagnosis27-Jun-19$150.00UnknownAcute pneumoniaAmoxicillin, ClavulanateFormer 5-15 cigs/day for over 20 yearsC16.4StomachChronic gastroduodenitisN/ANo
EDP0000-CV900095993032219DDStomach CancerVietnamK2 EDTA Plasma2.00$150.0042 YMaleNon-Hispanic<-70C22-Mar-19Clinical DiagnosisStomach CancerStagingT2NXMX14-Mar-19Additional NotesTumor pathology: adenocarcinoma. Endoscopy: ulcer and tumor in pylorus. CAT scan: cirrhosis, splenomegaly$150.00UnknownOmeprazoleUnknownNAStomachCirrhosis by alcohol since 2016U/A
EDP0000-CV900096302031819DDStomach CancerVietnamK2 EDTA Plasma0.502.00$75.0071 YFemaleNon-Hispanic<-70C18-Mar-19Clinical DiagnosisStomach CancerStagingN1M1Date N/AAdditional NotesEndoscopy: tumor in stomach 1x1.5 cm, ucler. Pathology: adenocarcinoma.$75.00UnknownOmeprazole, MetforminPostmenopausalNAStomachHypertension, DiabetesAbdominal lymph nodes
EDP0000-CV900098050050419DDStomach CancerVietnamK2 EDTA Plasma1.002.00$150.0071 YMaleNon-Hispanic<-70C04-May-19Clinical DiagnosisStomach Cancer (Gastric)StagingIV TXN3M111-May-19Additional NotesEndoscopy: tumor in stomach. Pathology: adenocarcinoma. CT Scan: multiple lesions in neck max. 3.0x2.5 cm$150.00UnknownNoneUnknownNAStomachHypertension > 10 yearsLiver, Lymph nodes
EDP0000-CV900098054061819DDStomach CancerVietnamK2 EDTA Plasma1.002.00$150.0021 YFemaleNon-Hispanic<-70C18-Jun-19Clinical DiagnosisStomach CancerStagingIia T1bN2M0G33-Jun-19Additional NotesPathology: Adenocarcinoma. Endoscopy: ulcer 0.4 cm in stomach bulge. CT scan: normal$150.00UnknownOmeprazolePremenopausalNAStomachNoneLymph nodes
EDP0000-CV900098695040419DDStomach CancerVietnamK2 EDTA Plasma1.002.00$150.0085 YMaleNon-Hispanic<-70C04-Apr-19Clinical DiagnosisStomach CancerStagingIV T4N3M0G22-Apr-19Additional NotesPathology: Adenocarcinoma grade II. Endoscopy: tumor with ulcer$150.00UnknownNoneUnknownNAStomachHypertensionAbdominal lymph nodes
EDP0000-CV900398757030819D5Stomach CancerVietnamK2 EDTA Plasma0.354.00$150.0052 YMaleNon-Hispanic<-70C08-Mar-19Clinical DiagnosisStomach CancerStagingIV; T4N3M1G42019-03-07Date of Primary Tumor Diagnosis2019-02-26$150.00Unknown2019-03-08Omeprazole, Ultracet69.69163StomachHypertensionLymph node, Bone, LungNoCA 72-4: 1.35 U/mL | CA 19-9: 21.9 U/mL | CEA: 36.04 U/mL | 21-Feb-2019 | HBsAg - Positive | 19-Feb-2019 |
EDP0000-CV900398758030619D5Stomach CancerVietnamK2 EDTA Plasma0.354.00$150.0063 YMaleNon-Hispanic<-70C06-Mar-19Clinical DiagnosisStomach CancerStagingII; T2NXM0Date of Primary Tumor Diagnosis2019-03-04$150.00Unknown2019-03-06Nexium65.75117StomachNoneU/ANoCA 72-4: 1.56 U/mL | CEA: 6.18 U/mL | 27-Feb-2019 |
EDP0000-CV900398763030719D4Stomach CancerVietnamK2 EDTA Plasma0.353.00$150.0069 YMaleNon-Hispanic<-70C07-Mar-19Clinical DiagnosisStomach CancerStagingIV; T3N3MXDate of Primary Tumor Diagnosis2019-02-25$150.00Unknown2019-03-07Omeprazole, Amlodipine62.60128StomachHypertensionLymph nodesNoCEA: 3.75 U/mL | 19-Feb-2019 |
LHP0000-CV900398757030819DDStomach CancerVietnamL. Heparin Plasma0.353.00$150.0052 YMaleNon-Hispanic<-70C08-Mar-19Clinical DiagnosisStomach CancerStagingIV; T4N3M1G42019-03-07Date of Primary Tumor Diagnosis2019-02-26$150.00Unknown2019-03-08Omeprazole, Ultracet69.69163StomachHypertensionLymph node, Bone, LungNoCA 72-4: 1.35 U/mL | CA 19-9: 21.9 U/mL | CEA: 36.04 U/mL | 21-Feb-2019 | HBsAg - Positive | 19-Feb-2019 |
LHP0000-CV900398758030619DDStomach CancerVietnamL. Heparin Plasma0.354.00$150.0063 YMaleNon-Hispanic<-70C06-Mar-19Clinical DiagnosisStomach CancerStagingII; T2NXM0Date of Primary Tumor Diagnosis2019-03-04$150.00Unknown2019-03-06Nexium65.75117StomachNoneU/ANoCA 72-4: 1.56 U/mL | CEA: 6.18 U/mL | 27-Feb-2019 |
LHP0000-CV900398763030719D3Stomach CancerVietnamL. Heparin Plasma0.353.00$150.0069 YMaleNon-Hispanic<-70C07-Mar-19Clinical DiagnosisStomach CancerStagingIV; T3N3MXDate of Primary Tumor Diagnosis2019-02-25$150.00Unknown2019-03-07Omeprazole, Amlodipine62.60128StomachHypertensionLymph nodesNoCEA: 3.75 U/mL | 19-Feb-2019 |
NAP0000-CV900398757030819DDStomach CancerVietnamS. Heparin Plasma0.353.00$150.0052 YMaleNon-Hispanic<-70C08-Mar-19Clinical DiagnosisStomach CancerStagingIV; T4N3M1G42019-03-07Date of Primary Tumor Diagnosis2019-02-26$150.00Unknown2019-03-08Omeprazole, Ultracet69.69163StomachHypertensionLymph node, Bone, LungNoCA 72-4: 1.35 U/mL | CA 19-9: 21.9 U/mL | CEA: 36.04 U/mL | 21-Feb-2019 | HBsAg - Positive | 19-Feb-2019 |
NAP0000-CV900398758030619DDStomach CancerVietnamS. Heparin Plasma0.352.00$150.0063 YMaleNon-Hispanic<-70C06-Mar-19Clinical DiagnosisStomach CancerStagingII; T2NXM0Date of Primary Tumor Diagnosis2019-03-04$150.00Unknown2019-03-06Nexium65.75117StomachNoneU/ANoCA 72-4: 1.56 U/mL | CEA: 6.18 U/mL | 27-Feb-2019 |
NAP0000-CV900398763030719D3Stomach CancerVietnamS. Heparin Plasma0.353.00$150.0069 YMaleNon-Hispanic<-70C07-Mar-19Clinical DiagnosisStomach CancerStagingIV; T3N3MXDate of Primary Tumor Diagnosis2019-02-25$150.00Unknown2019-03-07Omeprazole, Amlodipine62.60128StomachHypertensionLymph nodesNoCEA: 3.75 U/mL | 19-Feb-2019 |
NCP0000-G2900365161112919DDStomach CancerUkraineNa. Citrate Plasma0.501.00Special Order.
Please Inquire
56 YFemaleNon-Hispanic<-70C29-Nov-19Clinical DiagnosisCancer of the stomach, T1-2NxM0, stage IIDisease StatusPrimaryMost Recent StagingT3N0M0; IIA, G3Special Order.
Please Inquire
UnknownEssential hypertension, grade II2019-11-2967.72243Never usedGastrointestinal tract | There is a neoplastic process of the stomach, an infiltrative form.
2019-11-14
Stomach | There is a defect in the lower third of the body of the stomach with a transition to the antrum.
2019-11-20
Stomach | There is a carcinoma, G3.
2019-11-19
Negative
2019-11-29
Never usedSubtotal gastrectomy | Stomach, NOS
2019-11-29
Body of stomach
3.0 x 1.4
Carcinoma of the stomach, G3. Tumor penetrates the subserosal connective tissue. There are signs of lymphovascular invasion. No perineural invasion. There are no metastases in the lymph nodes.Carcinoma
PST0000-CV900398757030819DDStomach CancerVietnamPST0.353.00$150.0052 YMaleNon-Hispanic<-70C08-Mar-19Clinical DiagnosisStomach CancerStagingIV; T4N3M1G42019-03-07Date of Primary Tumor Diagnosis2019-02-26$150.00Unknown2019-03-08Omeprazole, Ultracet69.69163StomachHypertensionLymph node, Bone, LungNoCA 72-4: 1.35 U/mL | CA 19-9: 21.9 U/mL | CEA: 36.04 U/mL | 21-Feb-2019 | HBsAg - Positive | 19-Feb-2019 |
PST0000-CV900398758030619D3Stomach CancerVietnamPST0.354.00$150.0063 YMaleNon-Hispanic<-70C06-Mar-19Clinical DiagnosisStomach CancerStagingII; T2NXM0Date of Primary Tumor Diagnosis2019-03-04$150.00Unknown2019-03-06Nexium65.75117StomachNoneU/ANoCA 72-4: 1.56 U/mL | CEA: 6.18 U/mL | 27-Feb-2019 |
PST0000-CV900398763030719DDStomach CancerVietnamPST0.353.00$150.0069 YMaleNon-Hispanic<-70C07-Mar-19Clinical DiagnosisStomach CancerStagingIV; T3N3MXDate of Primary Tumor Diagnosis2019-02-25$150.00Unknown2019-03-07Omeprazole, Amlodipine62.60128StomachHypertensionLymph nodesNoCEA: 3.75 U/mL | 19-Feb-2019 |
SST0000-AA900022548080319DDStomach CancerRussiaSST1.501.00$75.0059 YFemaleNon-Hispanic<-70C03-Aug-19Clinical DiagnosisAdenocarcinoma of StomachEndoscopy, Ultrasound and CTStagingIib, T3N1M0G212-Aug-19Date of Initial Primary Tumor Diagnosis19-Jul-19$75.00UnknownNoneNoneFormer 10-15 cigs/day for over 10 yearsC16.2StomachChronic gastritisN/ANo
SST0000-AA900037629062819DDStomach CancerRussiaSST0.751.00$75.0072 YMaleNon-Hispanic<-70C28-Jun-19Clincal DiagnosisAdenocarcinoma of StomachMost Recent StagingIia; T3N0M0G27-Jul-19Date of Initial Primary Tumor Diagnosis16-Jun-19$75.00UnknownNoneUnknownFormer 15-20 cigs/day for over 25 yearsC16.2StomachGastric ulcerU/A
SST0000-AA900037631060519DDStomach CancerRussiaSST1.001.00$75.0051 YFemaleNon-Hispanic<-70C05-Jun-19Clinical DiagnosisAdenocarcinoma of StomachEndoscopy, Ultrasound, CT and MRIStagingIia, T2NXM0G316-Jun-19Date of Initial Primary Tumor Diagnosis20-May-19$75.00UnknownNoneNoneCurrent 10-15 cigs/day for over 20 yearsC16.1StomachNoN/ANo
SST0000-AA900099086070219DDStomach CancerRussiaSST0.501.00$75.0060 YFemaleHispanic<-70C02-Jul-19Clinical DiagnosisAdenocarcinoma of StomachEndoscopy, CT and MRIStagingIib, T1N2M0G311-Jul-19Date of Initial Primary Tumor Diagnosis27-Jun-19$75.00UnknownAcute pneumoniaAmoxicillin, ClavulanateFormer 5-15 cigs/day for over 20 yearsC16.4StomachChronic gastroduodenitisN/ANo
SST0000-CV900095993032219DDStomach CancerVietnamSST1.001.00$150.0042 YMaleNon-Hispanic<-70C22-Mar-19Clinical DiagnosisStomach CancerStagingT2NXMX14-Mar-19Additional NotesTumor pathology: adenocarcinoma. Endoscopy: ulcer and tumor in pylorus. CAT scan: cirrhosis, splenomegaly$150.00UnknownOmeprazoleUnknownNAStomachCirrhosis by alcohol since 2016U/A
SST0000-CV900096302031819DDStomach CancerVietnamSST1.001.00$150.0071 YFemaleNon-Hispanic<-70C18-Mar-19Clinical DiagnosisStomach CancerStagingN1M1Date N/AAdditional NotesEndoscopy: tumor in stomach 1x1.5 cm, ucler. Pathology: adenocarcinoma.$150.00UnknownOmeprazole, MetforminPostmenopausalNAStomachHypertension, DiabetesAbdominal lymph nodes
SST0000-CV900098050050419DDStomach CancerVietnamSST1.001.00$150.0071 YMaleNon-Hispanic<-70C04-May-19Clinical DiagnosisStomach Cancer (Gastric)StagingIV TXN3M111-May-19Additional NotesEndoscopy: tumor in stomach. Pathology: adenocarcinoma. CT Scan: multiple lesions in neck max. 3.0x2.5 cm$150.00UnknownNoneUnknownNAStomachHypertension > 10 yearsLiver, Lymph nodes
SST0000-CV900098054061819DDStomach CancerVietnamSST1.001.00$150.0021 YFemaleNon-Hispanic<-70C18-Jun-19Clinical DiagnosisStomach CancerStagingIia T1bN2M0G33-Jun-19Additional NotesPathology: Adenocarcinoma. Endoscopy: ulcer 0.4 cm in stomach bulge. CT scan: normal$150.00UnknownOmeprazolePremenopausalNAStomachNoneLymph nodes
SST0000-CV900098695040419DDStomach CancerVietnamSST1.001.00$150.0085 YMaleNon-Hispanic<-70C04-Apr-19Clinical DiagnosisStomach CancerStagingIV T4N3M0G22-Apr-19Additional NotesPathology: Adenocarcinoma grade II. Endoscopy: tumor with ulcer$150.00UnknownNoneUnknownNAStomachHypertensionAbdominal lymph nodes
SST0000-CV900398758030619D3Stomach CancerVietnamSST0.353.00$150.0063 YMaleNon-Hispanic<-70C06-Mar-19Clinical DiagnosisStomach CancerStagingII; T2NXM0Date of Primary Tumor Diagnosis2019-03-04$150.00Unknown2019-03-06Nexium65.75117StomachNoneU/ANoCA 72-4: 1.56 U/mL | CEA: 6.18 U/mL | 27-Feb-2019 |
SST0000-CV900398763030719D4Stomach CancerVietnamSST0.353.00$150.0069 YMaleNon-Hispanic<-70C07-Mar-19Clinical DiagnosisStomach CancerStagingIV; T3N3MXDate of Primary Tumor Diagnosis2019-02-25$150.00Unknown2019-03-07Omeprazole, Amlodipine62.60128StomachHypertensionLymph nodesNoCEA: 3.75 U/mL | 19-Feb-2019 |
STO0000-G2900354486111919DDStomach CancerUkraineStool3.001.00Special Order.
Please Inquire
70 YMaleNon-Hispanic<-70C19-Nov-19StagingIIStomach body cancerSpecial Order.
Please Inquire
Unknown
STO0000-G2900355221111419DDStomach CancerUkraineStool5.001.00Special Order.
Please Inquire
71 YFemaleNon-Hispanic<-70C14-Nov-19StagingIVStomach CancerSpecial Order.
Please Inquire
Unknown
STO0000-G2900360124121619DDStomach CancerUkraineStool8.001.00Special Order.
Please Inquire
54 YMaleNon-Hispanic<-70C16-Dec-19DiagnosisStomach Cancer, stage IIISpecial Order.
Please Inquire
Unknown
STO0000-G2900371512121719DDStomach CancerUkraineStool1.001.00$150.0045 YFemaleNon-Hispanic<-70C17-Dec-19DiagnosisStomach cancer, stage III$150.00Unknown
STO0000-G2900371556112619DDStomach CancerUkraineStool1.001.00$150.0079 YMaleNon-Hispanic<-70C26-Nov-19StagingIIStomach Cancer$150.00Unknown
STO0000-G2900371557110419DDStomach CancerUkraineStool1.001.00$150.0062 YFemaleNon-Hispanic<-70C04-Nov-19StagingIIStomach Cancer$150.00Unknown
STO0000-G2900371558111419DDStomach CancerUkraineStool1.001.00$150.0044 YFemaleNon-Hispanic<-70C14-Nov-19StagingIIIStomach Cancer$150.00Unknown
STO0000-G2900388009012020DDStomach CancerUkraineStool6.001.00Special Order.
Please Inquire
64 YFemaleNon-Hispanic<70C20-Jan-20DiagnosisStomach CancerStomach CancerSpecial Order.
Please Inquire
Unknown

Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.

Please read carefully before purchasing:

Clinical specimens for research use only.

Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.

If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341

These products are supplied without warranty for suitability for specific applications or analytical determinations.

Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.